Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071292 · ClinicalTrials.gov registry record · Phase 2
Meditation-Based Stress Reduction in Rheumatoid Arthritis
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT00071292 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 80 participants.
The verdict
NCT00071292, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).
Interventions
- BEHAVIORAL stress reduction program
- BEHAVIORAL meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2003-07 |
| Est. Completion | 2005-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00071292
The ClinicalTrials.gov registry entry for NCT00071292 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which stress reduction program is the first listed.
NCT00071292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00071292 about?
NCT00071292 is a clinical study titled "Meditation-Based Stress Reduction in Rheumatoid Arthritis". The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).
What is the current status of trial NCT00071292?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2003-07. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00071292?
The interventions under investigation include: stress reduction program (BEHAVIORAL), meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00071292?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.